title: Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model.
abstract: OBJECTIVE
  Cisplatin is a commonly used chemotherapeutic agent. One of its major dose-limiting side effects is ototoxicity. No treatment has yet been approved for this condition. The objective of this study was to determine the potential protective effect of a systemic administration of erdosteine against cisplatin-induced ototoxicity.
  
  
  METHODS
  A prospective controlled trial conducted in an animal model.
  
  
  METHODS
  Animal care research facilities of The Montreal Children's Hospital Research Institute.
  
  
  METHODS
  A total of 27 guinea pigs were assigned to 4 groups, each receiving a different concentration of intraperitoneal erdosteine: group 1 (control group; n = 9) did not receive erdosteine, group 2 (n = 6) received 100 mg/kg/d, group 3 (n = 6) received 200 mg/kg/d, and group 4 (n = 6) received 500 mg/kg/d. The animals in the experimental groups received the erdosteine injection daily for 4 days. All of the animals received 12 mg/kg of intraperitoneal cisplatin. Auditory brainstem response threshold shifts were measured at 4 frequencies (8, 16, 20, and 25 kHz) for all groups. Scanning electron microscopy and outer hair cell counts were performed to assess the protective effect of erdosteine.
  
  
  RESULTS
  Significant protection was observed in groups 3 and 4 at 25 kHz. These findings are supported by outer hair cell counts by scanning electron microscopy.
  
  
  CONCLUSIONS
  A systemic administration of erdosteine appears to provide an otoprotective effect at high frequencies for cisplatin-induced ototoxicity.
authors: McGill University, Montreal, Quebec, Canada.
authors: Sofia
authors: S
authors: Waissbluth
authors: Isabelle
authors: I
authors: Dupuis
authors: Sam J
authors: SJ
authors: Daniel
mesh_terms: D000818:Animals; D002945:Cisplatin / Q000633:toxicity*; D004427:Ear Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D008855:Microscopy, Electron, Scanning; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D013864:Thioglycolates / Q000008:administration & dosage / Q000494:pharmacology*; D013876:Thiophenes / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D013864:Thioglycolates; D013876:Thiophenes; C048498:erdosteine; D002945:Cisplatin